Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-6913 for Vasomotor Symptoms in Postmenopausal Women
NCT01015677Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-6913 in vasomotor symptoms, sponsored by Merck & Co.. Started Dec 2009; status: terminated.
02
Drugs
MK-6913
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT01015677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015677.